The investment blog Seeking Alpha says Johnson & Johnson is doing quite well financially despite its recent problems – including high-profile and costly recalls of faulty medical devices.
The report notes that Warren Buffett’s Berkshire Hathaway Inc. dropped two-thirds of its holdings in the company, following a $1.1 billion fine from an Arkansas jury that ruled the firm misled doctors and patients about the risks of antipsychotic medication Risperdal.
Johnson & Johnson ...
continue reading...